Dendritic cell subsets and type I diabetes: Focus upon DC-based therapy
- 31 July 2006
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (6), 419-423
- https://doi.org/10.1016/j.autrev.2005.12.001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Experimental study on induction of tolerance to experimental autoimmune myasthenia gravis by immature dendritic cellsJournal of Huazhong University of Science and Technology [Medical Sciences], 2005
- Autoimmune Diabetes Is Suppressed by Transfer of Proinsulin-Encoding Gr-1+ Myeloid Progenitor Cells That Differentiate In Vivo Into Resting Dendritic CellsDiabetes, 2005
- Dendritic cell-mediated T cell polarizationSpringer Seminars in Immunopathology, 2004
- Evaluation of in vivo labelled dendritic cell migration in cancer patientsJournal of Translational Medicine, 2004
- Cutting Edge: Differential Chemokine Production by Myeloid and Plasmacytoid Dendritic CellsThe Journal of Immunology, 2002
- Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?Trends in Immunology, 2002
- Dendritic cell lineage, plasticity and cross-regulationNature Immunology, 2001
- Phenotypic and Functional Characteristics of BM-Derived DC from NOD and Non-Diabetes-Prone StrainsClinical Immunology, 2001
- Immunotherapy of NOD mice with bone marrow-derived dendritic cells.Diabetes, 1999
- Immunobiology of DC in NOD miceJournal of Leukocyte Biology, 1999